Hexagon Capital Partners LLC Novavax Inc Transaction History

Hexagon Capital Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	SELL	$6.81 - $9.74 $81 - $116	-12 Reduced 24.0%	38 $0
Q2 2023 Jul 24, 2023	SELL	$6.67 - $9.52 $13 - $19	-2 Reduced 3.85%	50 $0
Q1 2023 Apr 24, 2023	SELL	$5.76 - $12.48 $1,088 - $2,358	-189 Reduced 78.42%	52 $0
Q4 2022 Jan 13, 2023	SELL	$8.86 - $25.04 $1,346 - $3,806	-152 Reduced 38.68%	241 $0
Q3 2022 Oct 17, 2022	BUY	$18.2 - $76.12 $7,152 - $29,915	393 New	393 $7,000

286

84.7M

5.38M

8.62M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $718M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Hexagon Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Hexagon Capital Partners LLC with notifications on news.